A PHASE I, COMBINED STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SZV-1287 IN HEALTHY MALE VOLUNTEERS AFTER SINGLE ASCENDING AND MULTIPLE ASCENDING ORAL DOSES FOR 14 DAYS

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519485-50-00

Acronym

SZV-1287-0020

Enrollment

Registered

2024-11-25

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neuropathic pain

None listed

Sex/Gender

Male

Age

18 Years to 64 Years

Hungary

None listed

Source: EU CTIS · Data processed: Feb 4, 2026